|
|
Volumn 24, Issue 5, 2004, Pages 1297-1304
|
|
Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CYCLIN B;
CYCLIN B1;
CYCLIN DEPENDENT KINASE 1;
KI 67 ANTIGEN;
MESSENGER RNA;
QUERCETIN;
TAMOXIFEN;
VASCULOTROPIN A;
ANIMAL;
ARTICLE;
CELL DIVISION;
COMPARATIVE STUDY;
DRUG COMBINATION;
DRUG EFFECT;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MICROCIRCULATION;
MOUSE;
MOUSE MUTANT;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PHOSPHORYLATION;
PROSTATE TUMOR;
VASCULARIZATION;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CDC2 PROTEIN KINASE;
CELL DIVISION;
CYCLIN B;
DRUG THERAPY, COMBINATION;
HUMANS;
KI-67 ANTIGEN;
MALE;
MICE;
MICE, SCID;
MICROCIRCULATION;
NEOVASCULARIZATION, PATHOLOGIC;
PHOSPHORYLATION;
PROSTATIC NEOPLASMS;
QUERCETIN;
RNA, MESSENGER;
TAMOXIFEN;
TRANSPLANTATION, HETEROLOGOUS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
MLCS;
MLOWN;
|
|
EID: 6944243800
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.24.5.1297 Document Type: Article |
|
Times cited : (55)
|
|
References (0)
|
